Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression.

Wei Q, Mu K, Li T, Zhang Y, Yang Z, Jia X, Zhao W, Huai W, Guo P, Han L.

Lab Invest. 2014 Jan;94(1):52-62. doi: 10.1038/labinvest.2013.126. Epub 2013 Oct 28.

2.

Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome.

Wei Q, Guo P, Mu K, Zhang Y, Zhao W, Huai W, Qiu Y, Li T, Ma X, Liu Y, Chen X, Han L.

Lab Invest. 2015 Jul;95(7):804-16. doi: 10.1038/labinvest.2015.63. Epub 2015 May 25.

3.

Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.

Zhang X, Zhang JH, Chen XY, Hu QH, Wang MX, Jin R, Zhang QY, Wang W, Wang R, Kang LL, Li JS, Li M, Pan Y, Huang JJ, Kong LD.

Antioxid Redox Signal. 2015 Apr 1;22(10):848-70. doi: 10.1089/ars.2014.5868.

4.

Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.

Lee S, Suh GY, Ryter SW, Choi AM.

Am J Respir Cell Mol Biol. 2016 Feb;54(2):151-60. doi: 10.1165/rcmb.2015-0231TR. Review.

5.

NLRP3 inflammasome activation is required for fibrosis development in NAFLD.

Wree A, McGeough MD, Peña CA, Schlattjan M, Li H, Inzaugarat ME, Messer K, Canbay A, Hoffman HM, Feldstein AE.

J Mol Med (Berl). 2014 Oct;92(10):1069-82. doi: 10.1007/s00109-014-1170-1. Epub 2014 May 28.

6.

Deregulated NLRP3 and NLRP1 inflammasomes and their correlations with disease activity in systemic lupus erythematosus.

Yang Q, Yu C, Yang Z, Wei Q, Mu K, Zhang Y, Zhao W, Wang X, Huai W, Han L.

J Rheumatol. 2014 Mar;41(3):444-52. doi: 10.3899/jrheum.130310. Epub 2013 Dec 15.

PMID:
24334646
7.

ER stress induces NLRP3 inflammasome activation and hepatocyte death.

Lebeaupin C, Proics E, de Bieville CH, Rousseau D, Bonnafous S, Patouraux S, Adam G, Lavallard VJ, Rovere C, Le Thuc O, Saint-Paul MC, Anty R, Schneck AS, Iannelli A, Gugenheim J, Tran A, Gual P, Bailly-Maitre B.

Cell Death Dis. 2015 Sep 10;6:e1879. doi: 10.1038/cddis.2015.248.

8.

Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury.

Huang H, Chen HW, Evankovich J, Yan W, Rosborough BR, Nace GW, Ding Q, Loughran P, Beer-Stolz D, Billiar TR, Esmon CT, Tsung A.

J Immunol. 2013 Sep 1;191(5):2665-79. doi: 10.4049/jimmunol.1202733. Epub 2013 Jul 31.

9.

Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye.

Zheng Q, Ren Y, Reinach PS, She Y, Xiao B, Hua S, Qu J, Chen W.

Exp Eye Res. 2014 Aug;125:1-8. doi: 10.1016/j.exer.2014.05.001. Epub 2014 May 14.

PMID:
24836981
10.

Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.

Fan SH, Wang YY, Lu J, Zheng YL, Wu DM, Li MQ, Hu B, Zhang ZF, Cheng W, Shan Q.

PLoS One. 2014 Feb 26;9(2):e89961. doi: 10.1371/journal.pone.0089961. eCollection 2014.

12.

NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.

Satoh M, Tabuchi T, Itoh T, Nakamura M.

Clin Sci (Lond). 2014 Feb;126(3):233-41. doi: 10.1042/CS20130043.

PMID:
23944632
13.

Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke.

Fann DY, Lee SY, Manzanero S, Tang SC, Gelderblom M, Chunduri P, Bernreuther C, Glatzel M, Cheng YL, Thundyil J, Widiapradja A, Lok KZ, Foo SL, Wang YC, Li YI, Drummond GR, Basta M, Magnus T, Jo DG, Mattson MP, Sobey CG, Arumugam TV.

Cell Death Dis. 2013 Sep 5;4:e790. doi: 10.1038/cddis.2013.326.

14.

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH.

Wan X, Xu C, Yu C, Li Y.

Can J Gastroenterol Hepatol. 2016;2016:6489012. doi: 10.1155/2016/6489012. Epub 2016 May 4. Review.

15.

Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis.

Csak T, Pillai A, Ganz M, Lippai D, Petrasek J, Park JK, Kodys K, Dolganiuc A, Kurt-Jones EA, Szabo G.

Liver Int. 2014 Oct;34(9):1402-13. doi: 10.1111/liv.12537. Epub 2014 Apr 17.

16.
17.

Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.

Rajamäki K, Nordström T, Nurmi K, Åkerman KE, Kovanen PT, Öörni K, Eklund KK.

J Biol Chem. 2013 May 10;288(19):13410-9. doi: 10.1074/jbc.M112.426254. Epub 2013 Mar 25.

18.

NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice.

Wree A, Eguchi A, McGeough MD, Pena CA, Johnson CD, Canbay A, Hoffman HM, Feldstein AE.

Hepatology. 2014 Mar;59(3):898-910. doi: 10.1002/hep.26592. Epub 2014 Jan 30.

19.
20.

Carbon monoxide negatively regulates NLRP3 inflammasome activation in macrophages.

Jung SS, Moon JS, Xu JF, Ifedigbo E, Ryter SW, Choi AM, Nakahira K.

Am J Physiol Lung Cell Mol Physiol. 2015 May 15;308(10):L1058-67. doi: 10.1152/ajplung.00400.2014. Epub 2015 Mar 13.

Supplemental Content

Support Center